Tirzepatide Approved for Weight Loss

News

type 2 diabetes, weight loss

Tirzepatide produces clinically meaningful weight loss for at least 3 years in non-diabetic overweight adults: Trial

Once-weekly treatment with tirzepatide can produce clinically meaningful and sustained weight loss for at least three years in adults with overweight or obesity who do not have diabetes, according to new research being presented at the European Congress on Obesity (ECO) in Malaga,

FOX News on MSN · 4h

First GLP-1 pill for weight loss, diabetes shows success in late-phase trial

Eli Lilly has seen positive results from a phase 3 trial of Orforglipron, the first-ever GLP-1 pill for weight loss and type 2 diabetes. Previous versions were administered via injection.

Reuters on MSN · 4h

Lilly weight-loss pill works as well as Ozempic, shares surge

Eli Lilly's experimental pill worked as well as blockbuster drug Ozempic to lower weight and blood sugar in a trial of diabetes patients, and the company said it expects to seek regulatory approvals by the end of the year.

Verywell Health on MSN4h

Zepbound Helps Keep Weight Off for 3 Years, Study Finds

Fact checked by Nick Blackmer Zepbound supports sustained weight loss for up to three years among adults with obesity and ...

2don MSN

Study captures sharp uptake in use of new weight loss and glucose-lowering medications

When it comes to managing weight loss and type 2 diabetes with medications, research shows that it's out with the old and in ...

Medindia1d

Tirzepatide Surges in Popularity for Diabetes and Obesity Treatment

Tirzepatide and GLP-1 receptor agonists are replacing older treatments, marking a shift in how diabetes and weight loss are ...

The American Journal of Managed Care3d

Tirzepatide Surges, Overtakes Older Drugs in Diabetes, Obesity Care

Tirzepatide is approved for 3 indications in the US: type 2 diabetes, chronic weight management, and obstructive sleep apnea.

AOL3d

New drug tirzepatide delivers significant and long-lasting weight loss

“Our long-term analysis of tirzepatide establishes that clinically relevant weight loss can be sustained for ... developed by Eli Lilly and Company, was approved by the U.S. FDA under the ...

Gulf News4d

FDA-approved drug offers long-term weight loss in adults without diabetes

Also In This Package How fasting helps in sustainable weight loss Don't skip cheese in ... receptors to signal fullness or satiety. Tirzepatide was approved in November 2023 by the US Food and ...

12h

Weight-loss pill ‘works as well as Ozempic’ in new trial

Eli Lilly’s study of its tablet, orforglipron, has raised hopes of an effective and easy-to-use treatment reaching a market ...

ABC7 KABC6d

Tirzepatide, also known as Mounjaro or Zepbound, may help treat sleep apnea

You may know about tirzepatide, also known as Mounjaro or Zepbound, due to its popularity for those looking to lose weight or treat diabetes. Now, researchers have gotten it approved to treat sleep ...

Meghan Trainor and Husband Daryl Sabara Are Both Taking Mounjaro for Weight Loss: We ‘Do Everything Together’

Meghan Trainor said she’s been taking Mounjaro for weight loss alongside her husband, ‘Spy Kids’ actor Daryl Sabara. The ...

Science Daily1d

Sharp uptake in use of new weight loss and glucose-lowering medications

Researchers found that by December 2023, more than 1 in 3 of the medications being started for type 2 diabetes treatment were GLP-1RA-based medications.

MPR1d

Tirzepatide Dispensations Increased Rapidly After Approval

By December 2023, 12.3% of all glucose-lowering medication dispensations were tirzepatide among adults with T2DM.

Some results have been hidden because they may be inaccessible to you

Show inaccessible results